City to counter anti-vaccine information after hearing from this survivor

Toronto's board of health will develop a strategy to counter false information about the safety of vaccines, officials decided on Monday after hearing from a woman who contracted polio at a young age.
Source: CBC | Health - Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Related Links:

[Dalsan Radio] Somalia will kick off a countrywide polio campaign of two rounds of immunisation to deliver monovalent oral vaccine type 2.
Source: AllAfrica News: Polio - Category: Infectious Diseases Source Type: news
[East African] Somalia will kick off a countrywide polio campaign of two rounds of immunisation to deliver monovalent oral vaccine type 2.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[Radio Dabanga] Khartoum -The UN Office for the Coordination of Humanitarian Affairs (OCHA) in Sudan reports in its latest bulletin that a large-scale measles and polio vaccination campaign has so far reached 9.1 million children in Sudan. In Jebel Marra in Darfur, more than 2,600 people fled their homes following fighting between two rebel factions in February. A number of aid organizations and the UN-AU Mission in Darfur (Unamid) have been plundered. Food insecurity in Sudan continues, despite a good harvest.
Source: AllAfrica News: Polio - Category: Infectious Diseases Source Type: news
[Guardian] The World Health Organisation (WHO) has alerted to a recent emergence and spread of new strains of vaccine-derived poliovirus type 2 (cVDPV2) in southern Nigeria and, especially Lagos.
Source: AllAfrica News: Polio - Category: Infectious Diseases Source Type: news
On 23 May 2019, WHO received notification through the Global Polio Laboratory Network (GPLN) of the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) from an environmental sample collected on 20 April 2019 in a hospital in Northern Cameroon which borders Borno state in Nigeria and Chad.
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
This study is registered with EudraCT, number 2017-000908-21 and ClinicalTrials.gov, number NCT03430349.FindingsBetween May 22 and Aug 22, 2017, 48 volunteers were screened, of whom 15 (31%) volunteers were excluded for reasons relating to the inclusion or exclusion criteria, three (6%) volunteers were not treated because of restrictions to the number of participants in each group, and 30 (63%) volunteers were sequentially allocated to groups (15 participants per group). Both novel OPV2 candidates were immunogenic and increased the median blood titre of serum neutralising antibodies; all participants were seroprotected aft...
Source: The Lancet - Category: General Medicine Source Type: research
Publication date: Available online 4 June 2019Source: The LancetAuthor(s): Kimberly M Thompson
Source: The Lancet - Category: General Medicine Source Type: research
[Premium Times] The Nigeria army will henceforth conduct polio vaccination in locations in Borno State made inaccessible to health workers by the Boko Haram insurgency, the Chief of Army Staff, Tukur Buratai, has said.
Source: AllAfrica News: Polio - Category: Infectious Diseases Source Type: news
Source: World Health Organization (WHO). Published: 5/29/2019. The 21st meeting of the Emergency Committee under the International Health Regulations (2005) (IHR) regarding the international spread of poliovirus was held on May 14, 2019, to review the data on wild poliovirus (WPV1) and circulating vaccine derived polioviruses (cVDPV). This Web page summarizes the meeting's discussions, conclusions, risk categories, recommendations, and additional considerations. (Text)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news
(CNN) — The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2. And then came the price tag: $2.125 million for a one-time treatment. The gene therapy, called Zolgensma, will be marketed by AveXis, whose parent company is Novartis. “Today’s approval marks another milestone in the transformational power of gene and cell therapies to treat a wide range of diseases,” Dr. Ned Sharpless, the FDA’s acting commissioner, said in a statement Friday. &ldqu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN Novartis Source Type: news
More News: Canada Health | Health | Polio | Polio Vaccine | Vaccines